In 2016, Phoremost entered into a collaboration with The Wistar Institute. TWI are leaders in cancer research and vaccine and immunotherapy development. I found the last paragraph in this press piece below interesting.
I wonder if Phoremost/TWI have a potential interest in targeting a vaccine for melanoma and if/whether PYC could play a role in this potential development, particularly with their latest and first results out with their FPP delivery technology effective in delivering their peptide in a mouse melanoma cancer vaccine model?
Tony
PYC Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)